Brind.

Steven Chapman was appointed as the CEO of Natera on August 14, 2025.

2 reports, 1 independent Updated Aug 14

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Steven Chapman was appointed as the CEO of Natera on August 14, 2025.

Who's involved

What this event is mainly about

Steven Chapman Natera

Keep exploring

The entities involved

Steven Chapman
English cricketer (born 1971)

Nothing else this week.
Natera
company in San Carlos, United States
- Natera and Fractyl Health, biotech companies, traded on the NASDAQ stock exchange on September 1, 2026.Mon 02:47
- Natera's Signatera test is undergoing a Phase III trial across US sites, sponsored by NRG Oncology, while facing patent litigation.Sun 02:44

Coverage

Newest first; wire copies grouped

Aug 14StockStory5 Revealing Analyst Questions From Natera’s Q2 Earnings Call Natera’s second quarter showed significant momentum, with management attributing strong revenue growth to broad-based gains in oncology, p
Aug 8StockStoryNatera (NASDAQ:NTRA) Delivers Strong Q2 Numbers, Stock Jumps 12.6% Genetic testing company Natera (NASDAQ:NTRA). reported Q2 CY2025 results topping the market’s revenue expectations , with sales up 3